New research finds that measuring water loss through the skin during food challenges can predict anaphylaxis before symptoms appear, increasing patient comfort and safety.

Researches in the US have completed a trial examining the safety and efficacy of sublingual immunotherapy and found it has potential for long lasting effects and is most effective in young children.

The biopharmaceutical company DBV Technologies is due to begin two safety trials for Viaskin Peanut in two age groups, known as COMFORT Toddlers and COMFORT Children.

An employee who was sacked after taking five days off work to recover from a near-fatal allergic reaction has successfully sued his employer on the grounds of disability discrimination.

A community pharmacist in Co Down, Northern Ireland, has been celebrated as a local hero after treating a woman with adrenaline after a bee sting caused an anaphylactic reaction

Researchers based at Birmingham Heartlands Hospital are inviting health professionals to take part in The FAIR Study to benefit patients from a South Asian Background with food allergies.

A small study has shown that a cancer drug called acalabrutinib improves tolerance to peanuts in the short term, making it the first drug to achieve rapid-onset prevention of IgE-induced food reactivity.

A new study published in Scientific Reports this October suggests that the asthma treatments omalizumab, benralizumab and mepolizumab are linked to a higher risk of anaphylactic reactions than other similar drugs.

The European Academy of Allergy and Clinical Immunology (EAACI) launched their latest guidelines for diagnosing IgE-mediated food allergy this October.